Matches in Wikidata for { <http://www.wikidata.org/entity/Q92970826> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q92970826 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q92970826 description "scientific article published on 06 April 2019" @default.
- Q92970826 description "wetenschappelijk artikel" @default.
- Q92970826 description "наукова стаття, опублікована 6 квітня 2019" @default.
- Q92970826 name "A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease" @default.
- Q92970826 name "A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease" @default.
- Q92970826 type Item @default.
- Q92970826 label "A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease" @default.
- Q92970826 label "A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease" @default.
- Q92970826 prefLabel "A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease" @default.
- Q92970826 prefLabel "A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease" @default.
- Q92970826 P1433 Q92970826-09D27ABB-02DA-4833-AF6A-EB8186090860 @default.
- Q92970826 P1476 Q92970826-FC207618-3AD5-4448-B10B-6B1A4CF784F9 @default.
- Q92970826 P2093 Q92970826-383CFFB0-DC33-40B7-92BC-1370E1D94FFD @default.
- Q92970826 P2093 Q92970826-4D303DDA-868E-4CA2-AC93-047283854871 @default.
- Q92970826 P2093 Q92970826-5CADD1A0-D737-45F4-81C0-345E3B7D4324 @default.
- Q92970826 P2093 Q92970826-62A633BF-C2A2-4C2C-8EA6-D09271D8905C @default.
- Q92970826 P2093 Q92970826-F13792D2-8E89-4FF0-8A1E-431F400608C3 @default.
- Q92970826 P304 Q92970826-F9D98B47-25D2-4DDB-B86F-9494F6180149 @default.
- Q92970826 P31 Q92970826-FFDD2A96-DCCF-4387-A4C7-3B3E6FFB75E3 @default.
- Q92970826 P356 Q92970826-3CB4FB75-4DA1-49AA-8824-0DED3E95B926 @default.
- Q92970826 P433 Q92970826-4CC3951C-5F77-4283-9072-FD27FDB6F296 @default.
- Q92970826 P478 Q92970826-FC07B5C0-46E0-4A0D-98A0-4A0DB48C83CA @default.
- Q92970826 P50 Q92970826-9FAFF494-52B4-49A6-9C9A-B353BA5E40F7 @default.
- Q92970826 P577 Q92970826-FCD781F0-746D-4576-B626-3F2B14F0DE2B @default.
- Q92970826 P698 Q92970826-1A7DA95B-916A-4E79-B801-B6AF6321945F @default.
- Q92970826 P921 Q92970826-B240449D-75E4-425A-8675-59CA02A255C3 @default.
- Q92970826 P356 J.OPHTHA.2019.03.050 @default.
- Q92970826 P698 30965064 @default.
- Q92970826 P1433 Q7098109 @default.
- Q92970826 P1476 "A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease" @default.
- Q92970826 P2093 "Angela Justice" @default.
- Q92970826 P2093 "Barry A Schechter" @default.
- Q92970826 P2093 "Damien F Goldberg" @default.
- Q92970826 P2093 "John D Sheppard" @default.
- Q92970826 P2093 "Ranjan P Malhotra" @default.
- Q92970826 P304 "1230-1237" @default.
- Q92970826 P31 Q13442814 @default.
- Q92970826 P356 "10.1016/J.OPHTHA.2019.03.050" @default.
- Q92970826 P433 "9" @default.
- Q92970826 P478 "126" @default.
- Q92970826 P50 Q57095093 @default.
- Q92970826 P577 "2019-04-06T00:00:00Z" @default.
- Q92970826 P698 "30965064" @default.
- Q92970826 P921 Q3041498 @default.